SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: Stockjet who wrote (1716)4/27/1998 3:13:00 PM
From: dougjn  Read Replies (1) | Respond to of 9523
 
What happens after days like this is that a tug of war ensuses. About whether rates will actually get raised or not. Lot more attention will be paid once again to strength of the economy indicators.

And...the momentum in momentum stocks gets broken. Numbers get crunched once again.

How much will Viagra actually add to 98 and 99 earnings will become a focus. It will no longer go up because it has gone up, or the general story sounds good. Valuation once again.

Or so it seems to me.

Doug



To: Stockjet who wrote (1716)4/27/1998 4:20:00 PM
From: B.REVERE  Read Replies (2) | Respond to of 9523
 
[stock split coming?]---s-8 filed by PFE ON 4/23/98 WITH SEC.


CALCULATION OF REGISTRATION FEE
===========================================================================================================
Proposed
Proposed Maximum
Amount Maximum Aggregate Amount of
Title of Securities to be Offering Price Offering Registration
to be Registered Registered Per Share(1) Price(1) Fee
-----------------------------------------------------------------------------------------------------------
Common Stock, $.05 par value............ 46,000,000 shs. $102.84375 $4,730,812,500 $1,395,589.69
===========================================================================================================

(1) Estimated to calculate the registration fee based on the average of the high
and low prices of Pfizer Inc. Common Stock for New York Stock Exchange
Composite Transactions on April 17, 1998, as reported in The Wall Street
Journal.

================================================================================